The effect of statin therapy on oxidative stress indices in patients with arterial hypertension and type 2 diabetes mellitus

被引:1
|
作者
Nemtsova, V. D. [1 ]
机构
[1] Kharkiv Natl Med Univ, Dept Clin Pharmacol & Internal Med, Kharkov, Ukraine
关键词
hypertension; diabetes mellitus type 2; statins; oxidative stress;
D O I
10.14739/2310-1210.2018.1.121876
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: to study the effect of statin therapy on the oxidative and antioxidant systems parameters in patients with arterial hypertension (AH) and cocomitant type 2 diabetes mellitus (DM2T). Materials and methods. 126 patients (55 males and 71 females, average age was 57.8 +/- 6.2 years) with AH stage II and compensated DM2T were divided into 2 groups: the 1 group - with AH and DM2T (n = 69), who were constantly taking statins (rosuvastatin 10 mg/day or atorvastatin 20 mg/day) for at least 1 year; the 2 group - patients with AH and DM2T (n = 57) who did not take statins. The control group included 20 healthy volunteers. The parameters of lipid and carbohydrate metabolism, the degree of insulin resistance (HOMA-IR), the state of the oxidant system (malonic dialdehyde level -MDA), the antioxidant system (the activity of glutathione peroxidase (GPO) and the level of sulfhydryl groups -SH-groups) were evaluated. The statistics was carried out using the Statistica software package, version 8.0. Results. In the 1st group only the levels of LDL cholesterol significantly differed from the control group (P < 0.05). In the 2nd group the levels of total cholesterol and LDL cholesterol were expected to be higher than in the 1st group (P < 0.05) and the control group (P < 0.05). Despite the higher level of fasting glucose in the 2nd group than in the 1st group, HOMA-IR in the 1st group was higher than in the 2nd group (7.48 +/- 1.76 and 7.17 +/- 1.54, respectively, P > 0.05). In the 1st group in comparison with the 2nd group unreliable increase in GPO and SH-groups levels on the background of the increase in MDA levels (P > 0.05) were observed. Conclusions. The use of statins in low doses in AH combined with DM2T was accompanied by a nonsignificant improvement of antioxidant protection parameters on the background of increased insulin resistance and increased activity of lipid peroxidation.
引用
收藏
页码:26 / 30
页数:5
相关论文
共 50 条
  • [31] Lipid metabolism in type 2 diabetes mellitus and statin therapy
    Yamada, Nobuhiro
    ENDOCRINE JOURNAL, 2010, 57 : S204 - S204
  • [32] Effect of Rosuvastatin on Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Prospective Interventional Study
    Thej, M. Keerthi
    Bitla, Aparna R.
    Pvln, Srinivasa Rao
    Sachan, Alok
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, 18 (06) : BC1 - BC6
  • [33] The effect of calcitriol on lipid profile and oxidative stress in hyperlipidemic patients with type 2 diabetes mellitus
    Eftekhari, Mohammad Hassan
    Akbarzadeh, Marzieh
    Dabbaghmanesh, Mohammad Hossein
    Hassanzadeh, Jafar
    ARYA ATHEROSCLEROSIS, 2014, 10 (02) : 82 - 88
  • [34] Statin therapy in patients with type 2 diabetes
    Lo, V
    Noviasky, J
    Nashelsky, J
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (05) : 866 - +
  • [35] ORTHOSTATIC HYPERTENSION IN NORMOTENSIVE PATIENTS PREDICTS PERMANENT ARTERIAL HYPERTENSION IN TYPE 2 DIABETES MELLITUS
    Nibouche, N.
    Lanasri, N.
    Chibane, A.
    Zeraoulia, F.
    Bachir-Cherif, A.
    Dahak, A.
    Makhlouf, L.
    Medjahed, A.
    Biad, A.
    JOURNAL OF HYPERTENSION, 2016, 34 : E12 - E12
  • [36] ASPIRIN'S EFFECT ON OXIDATIVE STRESS IN PATIENTS WITH TYPE II DIABETES MELLITUS
    Geske, J.
    Guyer, K.
    Muncy, I.
    Boisen, M.
    De La Torre, I. Garcia
    Lopez, L.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 85 - 85
  • [37] Statin and Aspirin Therapy for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
    Udell, Jacob A.
    Scirica, Benjamin M.
    Braunwald, Eugene
    Raz, Itamar
    Steg, Ph. Gabriel
    Davidson, Jaime
    Hirshberg, Boaz
    Bhatt, Deepak L.
    CLINICAL CARDIOLOGY, 2012, 35 (12) : 722 - 729
  • [38] STATIN THERAPY FOR DYSLIPIDEMIA AND CORONARY HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Cozma, M. A.
    Gaman, M. A.
    Dobrica, E. C.
    Gaman, A. M.
    Diaconu, C. C.
    JOURNAL OF HYPERTENSION, 2019, 37 : E250 - E251
  • [39] Effect of dapagliflozin on arterial stiffness in patients with type 2 diabetes mellitus
    Hidalgo Santiago, Juan Carlos
    Maraver Delgado, Juan
    Cayon Blanco, Manuel
    Lopez Saez, Juan Bosco
    Gomez-Fernandez, Pablo
    MEDICINA CLINICA, 2020, 154 (05): : 171 - 174
  • [40] Lipids and oxidative stress in type 2 diabetes mellitus
    Zamaklar, M
    Lalic, K
    Rajkovic, N
    Popovic, LJ
    Trifunovic, D
    Potpara, T
    Draskovic, D
    Vasovic, O
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 83 - 83